| Term 
 
        | Bacterial specific targets 1, cell wall Antibiotics that target the cell wall: penicillin G, ampicillin, methicillin, cephalosporins, vancomycin, clavulanic acid |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2, DNA Topoisomerase unique to bac which control the structure of DNA. Ciprofloxacin: a DNA structure inhibiting drug. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 3, RNA polymerase Rifampin RNA polymerase inhibitor that recognize bacteria's RNA over ours. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 4, Metabolic enzymes that are required for building the DNA Sulfonamide inhibit from PABA to DHFA Trimethoprim inhibit from DHFA to THFA, DHFA and THFA are critical in methyl transfer rxn during synthesis of thymidine. We don't have PABA. it's unique to bacteria
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5, Protein synthesis;  prokaryotic ribosome is different Chloramphenicol Erythromycin  Tetracycline  Aminoclycoside |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MIC= minimum [] that stop the bac MBC= minimum [] that kills the bac |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 modes of action of antibiotic   1: bactericidal   2: bacteriostatic  (can be lethal to immunosupressed patient)     |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antagonistic effects of bac-static and bac-cidal drug   won't work |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mechanisms of drug resistance   1, Mutation the drug sensitive ones are killed while the resistant, mutated ones survive and still divide. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2, Recombination   Bac A transfer resistant genes to Bac B |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acquisition of multi-drug resistance   happen by combination of resistant plasmid transfer units to create a large plasmid unit that has mutiple resistance.   created by pt receiving many kinds of antibiotics. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pros & Cons of Combination therapy   less mutation chance   chance for developing combination drug resistance |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Synergistic mechanism of action of 2 antibiotics     protein synthesis inhibitor couple with cell wall inhibitor. eg: Aminoglycoside |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Penicillin inhibit crosslinking of peptidoglycan chains   Transeptidase crosslink pentopeptide between D alanine and glycine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | PBP (penicillin binding protein)   gets inactivated once bound to penicillin.   when it's inactivated, cell lysis occur.   it's a protein target for penicillin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | PBP interact with beta lactam ring of penicillin   Bacteria has beta lactamase to degrade penicillin. Beta lactamase opens up beta lactam ring, result in penicilloic acid (penicillin allergy) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amidase an enzyme that cleave and release R chains of penicillin, then you replace with another R chain to make synthetic penicillin. This enzyme broden the spectrum of drug. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Penicillin subgroup:   naficillins: staphycoccal   ampicillins: both gram +/-, it's smaller than penicillin to cross through porin of gram - bac. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Gram + bac thick cell wall with PBP  few beta-lactamase Gram - bac thin cell wall much smaller target porins lots of beta-lactamases   |  | Definition 
 | 
        |  |